| Literature DB >> 32064274 |
Chen Liu1, Wu QiNan1, Lei XiaoTian1, Yang MengLiu2, Gan XiaGuang1, Leng WeiLing1, Liang ZiWen1, Zhang Ling3, Yang GangYi2, Chen Bing1.
Abstract
[This corrects the article DOI: 10.1155/2018/7653904.].Entities:
Year: 2020 PMID: 32064274 PMCID: PMC6996705 DOI: 10.1155/2020/1912058
Source DB: PubMed Journal: J Diabetes Res Impact factor: 4.011
Figure 1Subcellular localization of Par-4 and TERT in diabetes. (a) Western blot analysis of Par-4 and TERT expression in cytoplasmic and nuclear extracts in each group. (b) Apoptosis was detected via TUNEL staining in each group. (c) Immunocytochemistry analysis of Par-4 expression in each group. (d) Immunocytochemistry analysis of TERT expression in each group. (e) Expression of Par-4 and TERT, apoptosis rates, cell survival rates determined with MTT assays, and glucose-stimulated insulin secretion in each group. Compared with the C group (P < 0.05). #Compared with the H group (P < 0.05).
Figure 2Diabetes activates Par-4 and inhibits TERT and p-Akt, inducing islet β cell apoptosis. (a) Immunocytochemistry analysis of Par-4 and TERT expression in cytoplasmic and nuclear extracts in each group. (b) Apoptosis was detected via TUNEL staining in each group. (c) Western blots of Par-4, TERT, Akt, and p-Akt expression in each group. (d) Expression of Par-4 (A), TERT (B), Akt (C), p-Akt (D), apoptosis rates (E), secretion of Par-4 (F), the HOMA-β index (G), and glucose-stimulated insulin secretion (H) in each group. (e) Signal transduction via the Par-4/TERT-Akt pathway to induce islet β cell apoptosis in diabetes. Compared with the N group (P < 0.05). #Compared with the D group (P < 0.05).